Copyright © 2024 Dentistry Today. All Rights Reserved.
Industry News
Vivos Announces Strong Momentum and Revenue Growth Prospects in 2024
Vivos Therapeutics, Inc. (the “company” or “Vivos”) (NASDAQ: VVOS), a leading medical device and...
Industry News
Vivos Therapeutics Presents: “Empowering Women to Champion Airway”
Vivos Therapeutics is excited to announce “Empowering Women to Champion Airway,” a pioneering event...
Industry News
Vivos Achieves Landmark FDA Clearance for Sleep Apnea Solution
Vivos Therapeutics, Inc. (NASDAQ: VVOS), a prominent medical device and technology company specializing in...
Industry News
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
Vivos Therapeutics, Inc. (“Vivos” or the “company”) (NASDAQ: VVOS), a medical technology company focused...
Industry News
Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution
Vivos Therapeutics, Inc., a medical technology company focused on developing and commercializing innovative diagnostic and...
Industry News
Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea
Drs. Clete Kushida of Stanford and Cecilia Wu of University of Alberta to lead...
Industry News
FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea
Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused...
Industry News
Vivos Therapeutics Opens State of the Art International Training Center In Denver
Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused...
Industry News
Vivos Therapeutics Establishes Clinical Advisory Board
Vivos Therapeutics has established a clinical advisory board to drive adoption and growth of...